pharm-regulatory-compliance-995x60 pharm-regulatory-compliance-995x60

FEATURED ARTICLES

More Featured Articles

WHITE PAPERS & CASE STUDIES

More White Papers & Case Studies

PRODUCTS & SERVICES

HygroClip2 Advanced Humidity And Temperature Probes HygroClip2 Advanced Humidity And Temperature Probes

The HygroClip2 ADVANCED humidity and temperature probes offer you maximum repeatability and an accuracy of ±0.8 %RH and ±0.1 K.

Enterprise Asset Performance Management Software for Life Sciences, Pharma Enterprise Asset Performance Management Software for Life Sciences, Pharma

Technology, enabled by the Industrial Internet of Things (IIoT), is empowering organizations to shift to a holistic and operations-centric view where proactive and predictive maintenance (PdM) enables front line personnel in life sciences to act before costly failures occur.

NDA Approval And Post Approval Services NDA Approval And Post Approval Services

From 2006 through 2015, Patheon helped clients earn 92 NDA approvals. That’s  twice as many as any other CMO. Success brings more success at this stage. That’s because depth of experience, reliability of quality and refinement of processes are all important in the final push for regulatory approval and making the transition to commercial manufacturing.

More Products & Services

LIFE SCIENCE WEBINARS

  • Challenges And Opportunities in Development Of Biologic Drugs
    Challenges And Opportunities in Development Of Biologic Drugs

    Biologic drugs, including monoclonal antibodies are revolutionizing the treatment of human diseases. There are nearly 60 antibodies that are approved and over 300 or more biologic drugs are at various stages of drug development. And with the improved efficacy and growing number of disease targets for biologic drugs, these numbers are likely to continue to increase.

  • Optimize Biologic Drug Development With The Power Of Scientific Informatics
    Optimize Biologic Drug Development With The Power Of Scientific Informatics

    Many organizations in the pharmaceutical and biopharmaceutical industries have increased their efforts in biotherapeutic drug development to remain competitive by shifting their activities away from small molecule toward biologics drug development.

  • GS1 DataMatrix Barcode Grading Webinar
    GS1 DataMatrix Barcode Grading Webinar

    Recent US and EU serialization mandates have introduced the GS1 DataMatrix barcode symbology into a much wider role in the pharmaceutical supply chain. While linear barcodes have served as identifiers for SKU- and lot-specific information, the more compact GS1 DataMatrix is now being used as the designated carrier for the greater amounts of data needed to authenticate and track each bottle and carton of prescription drug product. As the role of the DataMatrix has expanded, so has the need to read it consistently and reliably throughout the supply chain.

  • Developing Site-Specifically Modified ADCs Using A Chemoenzymatic Approach
    Developing Site-Specifically Modified ADCs Using A Chemoenzymatic Approach

    Antibody-drug conjugates (ADCs) have become de rigueur for pharmaceutical oncology drug development pipelines. There are more than 40 ADCs undergoing clinical trials and many more in preclinical development. Get the latest on novel protein modification platform and its application to generate ADCs, including new conjugation chemistries and linkers.

More From Life Science Webinars